Product NDC: | 17478-080 |
Proprietary Name: | CAPASTAT SULFATE |
Non Proprietary Name: | Capreomycin |
Active Ingredient(s): | 1 g/1 & nbsp; Capreomycin |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17478-080 |
Labeler Name: | Akorn |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050095 |
Marketing Category: | NDA |
Start Marketing Date: | 20090801 |
Package NDC: | 17478-080-50 |
Package Description: | 1 INJECTION, POWDER, FOR SOLUTION in 1 CARTON (17478-080-50) |
NDC Code | 17478-080-50 |
Proprietary Name | CAPASTAT SULFATE |
Package Description | 1 INJECTION, POWDER, FOR SOLUTION in 1 CARTON (17478-080-50) |
Product NDC | 17478-080 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Capreomycin |
Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20090801 |
Marketing Category Name | NDA |
Labeler Name | Akorn |
Substance Name | CAPREOMYCIN SULFATE |
Strength Number | 1 |
Strength Unit | g/1 |
Pharmaceutical Classes | Antimycobacterial [EPC] |